{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:50:19Z","timestamp":1787237419228,"version":"build-2736575974"},"reference-count":127,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19-00584"],"award-info":[{"award-number":["PI19-00584"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/01404"],"award-info":[{"award-number":["PI22\/01404"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PMP22-00021"],"award-info":[{"award-number":["PMP22-00021"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["P2022\/BMD7379"],"award-info":[{"award-number":["P2022\/BMD7379"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.beem.2023.101741","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T18:48:58Z","timestamp":1675882138000},"page":"101741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["MicroRNAs in autoimmune thyroid diseases and their role as biomarkers"],"prefix":"10.1016","volume":"37","author":[{"given":"Rebeca","family":"Mart\u00ednez-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Marazuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2023.101741_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.beem.2023.101741_bib2","first-page":"10","article-title":"Cytokine targeting by miRNAs in autoimmune diseases","author":"Salvi","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.beem.2023.101741_bib3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/ni.3731","article-title":"The multiple pathways to autoimmunity","volume":"18","author":"Theofilopoulos","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.beem.2023.101741_bib4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.beem.2023.101741_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12026-012-8312-8","article-title":"Delineating the autoimmune mechanisms in Graves\u2019 disease","volume":"54","author":"Morshed","year":"2012","journal-title":"Immunol Res"},{"key":"10.1016\/j.beem.2023.101741_bib6","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2741\/4141","article-title":"The autoimmunity in Graves\u2019s disease","volume":"18","author":"Li","year":"2013","journal-title":"Front Biosci Landmark Ed"},{"key":"10.1016\/j.beem.2023.101741_bib7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40618-014-0097-2","article-title":"Extrathyroidal manifestations of Graves\u2019 disease: a 2014 update","volume":"37","author":"Bartalena","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.beem.2023.101741_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2265.2004.02085.x","article-title":"Cellular immune responses in autoimmune thyroid disease","volume":"61","author":"Weetman","year":"2004","journal-title":"Clin Endocrinol Oxf"},{"key":"10.1016\/j.beem.2023.101741_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12020-015-0759-7","article-title":"T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity","volume":"52","author":"Gonz\u00e1lez-Amaro","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2023.101741_bib10","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1210\/jc.2005-2337","article-title":"Regulatory T cells in human autoimmune thyroid disease","volume":"91","author":"Marazuela","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101741_bib11","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1210\/jc.2018-00498","article-title":"Patients with Autoimmune thyroiditis show diminished levels and defective suppressive function of Tr1 regulatory lymphocytes","volume":"103","author":"Vitales-Noyola","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101741_bib12","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.4049\/jimmunol.174.11.7433","article-title":"Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells","volume":"174","author":"Verginis","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.beem.2023.101741_bib13","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.4049\/jimmunol.0904135","article-title":"Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves\u2019 disease","volume":"186","author":"Mao","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.beem.2023.101741_bib14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2265.2009.03544.x","article-title":"Regulatory T cells in Graves\u2019 disease","volume":"71","author":"Pan","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2023.101741_bib15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/thy.2012.0514","article-title":"Impairment of regulatory T-cell function in autoimmune thyroid disease","volume":"23","author":"Glick","year":"2013","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"10.1016\/j.beem.2023.101741_bib16","unstructured":"Weetman A.P.W., DeGroot L.J. Autoimmunity to the thyroid gland. In: Thyroid disease manager. n.d."},{"key":"10.1016\/j.beem.2023.101741_bib17","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jc.2009-1719","article-title":"Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto\u2019s thyroiditis","volume":"95","author":"Figueroa-Vega","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101741_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12020-017-1361-y","article-title":"Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders","volume":"57","author":"Vitales-Noyola","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2023.101741_bib19","first-page":"23","article-title":"Insights into local orbital immunity: evidence for the involvement of the Th17 cell pathway in thyroid-associated ophthalmopathy","author":"Fang","year":"2018","journal-title":"J Clin Endocrinol"},{"key":"10.1016\/j.beem.2023.101741_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12036","article-title":"Th17 cell development: from the cradle to the grave","volume":"252","author":"Z\u00fa\u00f1iga","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.beem.2023.101741_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.autrev.2014.10.012","article-title":"Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions","volume":"14","author":"Grant","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.beem.2023.101741_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.32607\/20758251-2016-8-1-21-33","article-title":"MicroRNAs: the role in autoimmune inflammation","volume":"8","author":"Baulina","year":"2016","journal-title":"Acta Naturae"},{"key":"10.1016\/j.beem.2023.101741_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaci.2013.04.011","article-title":"MicroRNAs: essential players in the regulation of inflammation","volume":"132","author":"Rebane","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.beem.2023.101741_bib24","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/35002607","article-title":"The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans","volume":"403","author":"Reinhart","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.beem.2023.101741_bib25","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1038\/srep02940","article-title":"Exploration of miRNA families for hypotheses generation","volume":"3","author":"Kamanu","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2023.101741_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.beem.2023.101741_bib27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.beem.2023.101741_bib28","doi-asserted-by":"crossref","first-page":"D155","DOI":"10.1093\/nar\/gky1141","article-title":"miRBase: from microRNA sequences to function","volume":"47","author":"Kozomara","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.beem.2023.101741_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-3083.2011.02650.x","article-title":"MicroRNAs: emerging regulators of immune-mediated diseases","volume":"75","author":"Tomankova","year":"2012","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.beem.2023.101741_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1582-4934.2008.00534.x","article-title":"Advances in microRNAs: implications for immunity and inflammatory diseases","volume":"13","author":"Sonkoly","year":"2009","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.beem.2023.101741_bib31","doi-asserted-by":"crossref","first-page":"D98","DOI":"10.1093\/nar\/gkn714","article-title":"miR2Disease: a manually curated database for microRNA deregulation in human disease","volume":"37","author":"Jiang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.beem.2023.101741_bib32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2018.04.016","article-title":"Dysregulation of microRNAs in autoimmune diseases: pathogenesis, biomarkers and potential therapeutic targets","volume":"428","author":"Long","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.beem.2023.101741_bib33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1615\/CritRevImmunol.2013006858","article-title":"MicroRNA regulation of T-lymphocyte immunity: modulation of molecular networks responsible for T-cell activation, differentiation, and development","volume":"33","author":"Podshivalova","year":"2013","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.beem.2023.101741_bib34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/jir.2010.0037","article-title":"New perspectives in MicroRNA regulation of innate immunity","volume":"30","author":"Gantier","year":"2010","journal-title":"J Interferon Cytokine Res Off J Int Soc Interferon Cytokine Res"},{"key":"10.1016\/j.beem.2023.101741_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nri2957","article-title":"MicroRNAs: the fine-tuners of Toll-like receptor signalling","volume":"11","author":"O\u2019Neill","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.beem.2023.101741_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21062012","article-title":"Role of microRNAs in the development of cardiovascular disease in systemic autoimmune disorders","volume":"21","author":"Lopez-Pedrera","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2023.101741_bib37","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20080707","article-title":"Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity","volume":"205","author":"Zhou","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.beem.2023.101741_bib38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2011-05-355412","article-title":"The RNase III enzyme Dicer is essential for germinal center B-cell formation","volume":"119","author":"Xu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beem.2023.101741_bib39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1471-2474-11-209","article-title":"MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients","volume":"11","author":"Niimoto","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.beem.2023.101741_bib40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/cells11030452","article-title":"miRNAs as biomarkers and possible therapeutic strategies in rheumatoid arthritis","volume":"11","author":"Kmio\u0142ek","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.beem.2023.101741_bib41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2567.2009.03092.x","article-title":"MicroRNA in the immune system, microRNA as an immune system","volume":"127","author":"Lu","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.beem.2023.101741_bib42","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nmeth.1682","article-title":"Toward the blood-borne miRNome of human diseases","volume":"8","author":"Keller","year":"2011","journal-title":"Nat Methods"},{"key":"10.1016\/j.beem.2023.101741_bib43","volume":"106","year":"2015"},{"key":"10.1016\/j.beem.2023.101741_bib44","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1210\/jc.2017-02318","article-title":"A MicroRNA signature for evaluation of risk and severity of autoimmune thyroid diseases","volume":"103","author":"Mart\u00ednez-Hern\u00e1ndez","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101741_bib45","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3389\/fgene.2019.00570","article-title":"Epigenetic changes in the pathogenesis of rheumatoid arthritis","volume":"10","author":"Nemtsova","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.beem.2023.101741_bib46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/exd.13249","article-title":"Roles of microRNAs in psoriasis: immunological functions and potential biomarkers","volume":"26","author":"Liu","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.beem.2023.101741_bib47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/wrna.1208","article-title":"The origin, function, and diagnostic potential of extracellular microRNAs in human body fluids: extracellular microRNAs in human body fluids","volume":"5","author":"Liang","year":"2014","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.beem.2023.101741_bib48","first-page":"171","article-title":"Circulating extracellular microRNA in systemic autoimmunity","volume":"106","author":"Heegaard","year":"2015","journal-title":"Exp Suppl 2012"},{"key":"10.1016\/j.beem.2023.101741_bib49","first-page":"10","article-title":"Cytokine targeting by miRNAs in autoimmune diseases","author":"Salvi","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.beem.2023.101741_bib50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1479-5876-9-86","article-title":"Body fluid derived exosomes as a novel template for clinical diagnostics","volume":"9","author":"Keller","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.beem.2023.101741_bib51","first-page":"109","article-title":"Identification and Analysis of Circulating Exosomal microRNA in Human Body Fluids","volume":"1024","author":"L\u00e4sser","year":"2013"},{"key":"10.1016\/j.beem.2023.101741_bib52","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ki.2010.278","article-title":"Exosomes\/microvesicles as a mechanism of cell-to-cell communication","volume":"78","author":"Camussi","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.beem.2023.101741_bib53","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gks463","article-title":"Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes","volume":"40","author":"Wahlgren","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.beem.2023.101741_bib54","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2011-02-338004","article-title":"Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes","volume":"119","author":"Montecalvo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.beem.2023.101741_bib55","doi-asserted-by":"crossref","first-page":"E968","DOI":"10.1210\/jc.2011-2982","article-title":"Differential microRNA expression in peripheral blood mononuclear cells from Graves\u2019 disease patients","volume":"97","author":"Liu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101741_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0033-1361088","article-title":"microRNA expressions in CD4+ and CD8+ T-cell subsets in autoimmune thyroid diseases","volume":"122","author":"Bernecker","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.beem.2023.101741_bib57","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/gtmb.2011.0026","article-title":"MicroRNA 146a expression in rheumatoid arthritis: association with tumor necrosis factor-alpha and disease activity","volume":"15","author":"Abou-Zeid","year":"2011","journal-title":"Genet Test Mol Biomark"},{"key":"10.1016\/j.beem.2023.101741_bib58","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2010.08.012","article-title":"Function of miR-146a in controlling treg cell-mediated regulation of Th1 responses","volume":"142","author":"Lu","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.beem.2023.101741_bib59","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2023.101741_bib60","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.4049\/jimmunol.0803162","article-title":"Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells","volume":"182","author":"Kohlhaas","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.beem.2023.101741_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046082","article-title":"MicroRNA-155 modulates treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1","volume":"7","author":"Yao","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.beem.2023.101741_bib62","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1089\/thy.2012.0277","article-title":"MicroRNAs miR-146a1, miR-155_2, and miR-200a1 are regulated in autoimmune thyroid diseases","volume":"22","author":"Bernecker","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2023.101741_bib63","doi-asserted-by":"crossref","first-page":"E2620","DOI":"10.1210\/jc.2014-1883","article-title":"Integrative analysis of mRNA and miRNA array data reveals the suppression of retinoic acid pathway in regulatory T cells of Graves\u2019 disease","volume":"99","author":"Wang","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101741_bib64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12026-015-8643-3","article-title":"Decreased expression of microRNA-125a-3p upregulates interleukin-23 receptor in patients with Hashimoto\u2019s thyroiditis","volume":"62","author":"Peng","year":"2015","journal-title":"Immunol Res"},{"key":"10.1016\/j.beem.2023.101741_bib65","doi-asserted-by":"crossref","DOI":"10.1507\/endocrj.EJ15-0577","article-title":"Increases of microRNA let-7e in peripheral blood mononuclear cells in Hashimoto\u2019s disease","author":"Kagawa","year":"2016","journal-title":"Endocr J"},{"key":"10.1016\/j.beem.2023.101741_bib66","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fendo.2018.00264","article-title":"miR-29a-3p\/T-bet regulatory circuit is altered in T cells of patients with Hashimoto\u2019s thyroiditis","volume":"9","author":"Toki\u0107","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2023.101741_bib67","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s12020-015-0546-5","article-title":"MiR-346 regulates CD4+CXCR5+ T cells in the pathogenesis of Graves\u2019 disease","volume":"49","author":"Chen","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2023.101741_bib68","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3389\/fimmu.2017.01440","article-title":"MicroRNA-4443 causes CD4+ T cells dysfunction by targeting TNFR-associated factor 4 in Graves\u2019 disease","volume":"8","author":"Qi","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.beem.2023.101741_bib69","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1515\/hsz-2018-0343","article-title":"MiR-23a-3p-regulated abnormal acetylation of FOXP3 induces regulatory T cell function defect in Graves\u2019 disease","volume":"400","author":"Zhang","year":"2019","journal-title":"Biol Chem"},{"key":"10.1016\/j.beem.2023.101741_bib70","doi-asserted-by":"crossref","first-page":"9364","DOI":"10.1111\/jcmm.16876","article-title":"MiR\u2010363-5p modulates regulatory T cells through STAT4\u2013HSPB1\u2013Notch1 axis and is associated with the immunological abnormality in Graves\u2019 disease","volume":"25","author":"Yin","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.beem.2023.101741_bib71","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.beem.2023.101741_bib72","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/cen.12432","article-title":"Circulating microRNAs in autoimmune thyroid diseases","volume":"81","author":"Yamada","year":"2014","journal-title":"Clin Endocrinol Oxf"},{"key":"10.1016\/j.beem.2023.101741_bib73","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1089\/thy.2016.0062","article-title":"Circulating MicroRNAs in Graves\u2019 disease in relation to clinical activity","volume":"26","author":"Hiratsuka","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.beem.2023.101741_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22266","article-title":"Serum miR-146a, miR-155, and miR-210 as potential markers of Graves\u2019 disease","volume":"32","author":"Zheng","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.beem.2023.101741_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102472","article-title":"Utility of circulating serum miRNA profiles to evaluate the potential risk and severity of immune-mediated inflammatory disorders","volume":"111","author":"Mart\u00ednez-Hern\u00e1ndez","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.beem.2023.101741_bib76","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12967-018-1565-9","article-title":"Serum and thyroid tissue level of let-7b and their correlation with TRAb in Graves\u2019 disease","volume":"16","author":"Chen","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.beem.2023.101741_bib77","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/genes13020171","article-title":"Expression profiles of miR-22-5p and miR-142-3p indicate Hashimoto\u2019s disease and are related to thyroid antibodies","volume":"13","author":"Trummer","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.beem.2023.101741_bib78","doi-asserted-by":"crossref","first-page":"E1531","DOI":"10.1210\/jc.2015-3146","article-title":"Circulating microvesicles regulate treg and Th17 differentiation in human autoimmune thyroid disorders","volume":"100","author":"Rodriguez-Munoz","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101741_bib79","doi-asserted-by":"crossref","first-page":"8386","DOI":"10.1038\/s41598-018-26700-1","article-title":"Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves\u2019 disease and orbitopathy","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2023.101741_bib80","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.gene.2017.10.053","article-title":"Differential expression levels of plasma microRNA in Hashimoto\u2019s disease","volume":"642","author":"Zhao","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.beem.2023.101741_bib81","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12020-019-01884-2","article-title":"Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves\u2019 disease","volume":"65","author":"Yao","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2023.101741_bib82","first-page":"102","article-title":"MIR141 expression differentiates hashimoto thyroiditis from PTC and benign thyrocytes in Irish archival thyroid tissues","volume":"3","author":"Dorris","year":"2012","journal-title":"Front Endocrinol Lausanne"},{"key":"10.1016\/j.beem.2023.101741_bib83","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12967-016-0917-6","article-title":"MicroRNA-142-5p contributes to Hashimoto\u2019s thyroiditis by targeting CLDN1","volume":"14","author":"Zhu","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.beem.2023.101741_bib84","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/jclinpath-2016-203739","article-title":"Intermediate microRNA expression profile in Graves\u2019 disease falls between that of normal thyroid tissue and papillary thyroid carcinoma","volume":"70","author":"Pohl","year":"2017","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.beem.2023.101741_bib85","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1159\/000374002","article-title":"Aberrant expression of miRNA and mRNAs in lesioned tissues of Graves\u2019 disease","volume":"35","author":"Qin","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.beem.2023.101741_bib86","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ebiom.2019.10.061","article-title":"Integrated miRNA and mRNA expression profiling identifies novel targets and pathological mechanisms in autoimmune thyroid diseases","volume":"50","author":"Mart\u00ednez-Hern\u00e1ndez","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.beem.2023.101741_bib87","first-page":"1801","article-title":"MicroRNA-146a contributes to CD4+ T lymphocyte differentiation in patients with thyroid ophthalmopathy","volume":"9","author":"Yang","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.beem.2023.101741_bib88","first-page":"1803","article-title":"Decreased microRNA-146a in CD4+T cells promote ocular inflammation in thyroid-associated ophthalmopathy by targeting NUMB","volume":"21","author":"Hu","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.beem.2023.101741_bib89","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaut.2018.08.010","article-title":"MicroRNA-183 and microRNA-96 are associated with autoimmune responses by regulating T cell activation","volume":"96","author":"Thiel","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.beem.2023.101741_bib90","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12020-014-0487-4","article-title":"Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves\u2019 ophthalmopathy","volume":"49","author":"Shen","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2023.101741_bib91","doi-asserted-by":"crossref","first-page":"8578","DOI":"10.3390\/ijms23158578","article-title":"VIP\/VPAC axis expression in immune-mediated inflammatory disorders: associated miRNA signatures","volume":"23","author":"Lamana","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2023.101741_bib92","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1507\/endocrj.EJ14-0246","article-title":"Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of Graves\u2019 ophthalmopathy","volume":"61","author":"Wei","year":"2014","journal-title":"Endocr J"},{"key":"10.1016\/j.beem.2023.101741_bib93","article-title":"Plasma exosomes transfer miR-885-3p targeting the AKT\/NF\u03baB signaling pathway to improve the sensitivity of intravenous glucocorticoid therapy against graves ophthalmopathy","volume":"13","author":"Sun","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.beem.2023.101741_bib94","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U","article-title":"Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes","volume":"32","author":"Koumas","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.beem.2023.101741_bib95","first-page":"324","article-title":"MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy","volume":"21","author":"Tong","year":"2015","journal-title":"Mol Vis"},{"key":"10.1016\/j.beem.2023.101741_bib96","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1167\/iovs.15-18157","article-title":"PDGF-BB enhances the proliferation of cells in human orbital fibroblasts by suppressing PDCD4 expression Via Up-regulation of microRNA-21","volume":"57","author":"Lee","year":"2016","journal-title":"Investig Opthalmol Vis Sci"},{"key":"10.1016\/j.beem.2023.101741_bib97","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1167\/iovs.16-19213","article-title":"Role of miR-146a in the regulation of inflammation in an in vitro model of Graves\u2019 orbitopathy","volume":"57","author":"Jang","year":"2016","journal-title":"Investig Opthalmol Vis Sci"},{"key":"10.1016\/j.beem.2023.101741_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270416","article-title":"MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves\u2019 orbitopathy by repressing interleukin-2-inducible T-cell kinase","volume":"17","author":"Choi","year":"2022","journal-title":"PLOS ONE"},{"key":"10.1016\/j.beem.2023.101741_bib99","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/bjophthalmol-2017-310723","article-title":"Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves\u2019 orbitopathy","volume":"102","author":"Jang","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.beem.2023.101741_bib100","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1167\/iovs.19-27865","article-title":"TSHR signaling stimulates proliferation through PI3K\/Akt and induction of miR-146a and miR-155 in thyroid eye disease orbital fibroblasts","volume":"60","author":"Woeller","year":"2019","journal-title":"Investig Opthalmol Vis Sci"},{"key":"10.1016\/j.beem.2023.101741_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221077","article-title":"MicroRNA-27 inhibits adipogenic differentiation in orbital fibroblasts from patients with Graves\u2019 orbitopathy","volume":"14","author":"Jang","year":"2019","journal-title":"PLOS ONE"},{"key":"10.1016\/j.beem.2023.101741_bib102","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/iovs.62.1.29","article-title":"MicroRNA-130a is elevated in thyroid eye disease and increases lipid accumulation in fibroblasts through the suppression of AMPK","volume":"62","author":"Hammond","year":"2021","journal-title":"Investig Opthalmol Vis Sci"},{"key":"10.1016\/j.beem.2023.101741_bib103","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.3390\/biomedicines9121871","article-title":"The role of oxidative stress and therapeutic potential of antioxidants in Graves\u2019 ophthalmopathy","volume":"9","author":"Hou","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.beem.2023.101741_bib104","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/ijms23010153","article-title":"miR-199a downregulation as a driver of the NOX4\/HIF-1\u03b1\/VEGF-A pathway in thyroid and orbital adipose tissues from Graves\u2032 patients","volume":"23","author":"Craps","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2023.101741_bib105","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00018-016-2167-4","article-title":"Contribution of MicroRNAs to autoimmune diseases","volume":"73","author":"Garo","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.beem.2023.101741_bib106","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.imlet.2020.07.008","article-title":"A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases","volume":"227","author":"Mortazavi-Jahromi","year":"2020","journal-title":"Immunol Lett"},{"key":"10.1016\/j.beem.2023.101741_bib107","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.20101823","article-title":"miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice","volume":"208","author":"Boldin","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.beem.2023.101741_bib108","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1038\/s41467-018-05196-3","article-title":"Differential cell-intrinsic regulations of germinal center B and T cells by miR-146a and miR-146b","volume":"9","author":"Cho","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2023.101741_bib109","first-page":"1501","article-title":"Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review","volume":"71","author":"Xu","year":"2022","journal-title":"Inflamm Res Off J Eur Histamine Res Soc Al"},{"key":"10.1016\/j.beem.2023.101741_bib110","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.220070","article-title":"miR-155-3p: processing by-product or rising star in immunity and cancer?","volume":"12","author":"Dawson","year":"2022","journal-title":"Open Biol"},{"key":"10.1016\/j.beem.2023.101741_bib111","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neulet.2011.08.021","article-title":"Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis","volume":"504","author":"Fenoglio","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.beem.2023.101741_bib112","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/emmm.201100171","article-title":"Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice","volume":"3","author":"Garchow","year":"2011","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.beem.2023.101741_bib113","doi-asserted-by":"crossref","first-page":"12030","DOI":"10.1073\/pnas.1101450108","article-title":"The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death","volume":"108","author":"Ruan","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2023.101741_bib114","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jns.2015.06.019","article-title":"Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients","volume":"356","author":"Punga","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.beem.2023.101741_bib115","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/ijms17060864","article-title":"The MicroRNA-21 in autoimmune diseases","volume":"17","author":"Wang","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2023.101741_bib116","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1172\/JCI74347","article-title":"MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis","volume":"125","author":"Murugaiyan","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.beem.2023.101741_bib117","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.omtn.2017.06.005","article-title":"Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.beem.2023.101741_bib118","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/2229-3485.179431","article-title":"MicroRNA therapeutics: discovering novel targets and developing specific therapy","volume":"7","author":"Christopher","year":"2016","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.beem.2023.101741_bib119","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1158\/0008-5472.CAN-10-2010","article-title":"The promise of microRNA replacement therapy","volume":"70","author":"Bader","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2023.101741_bib120","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cell.2009.04.021","article-title":"Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model","volume":"137","author":"Kota","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.beem.2023.101741_bib121","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.beem.2023.101741_bib122","first-page":"2213","article-title":"Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis","volume":"187","author":"Murugaiyan","year":"2011","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.beem.2023.101741_bib123","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2013.09.019","article-title":"MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"266","author":"Zhang","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.beem.2023.101741_bib124","doi-asserted-by":"crossref","first-page":"18704","DOI":"10.1073\/pnas.0905063106","article-title":"Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease","volume":"106","author":"Mattes","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beem.2023.101741_bib125","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1101\/gad.1950610","article-title":"Repression of the miR-143\/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway","volume":"24","author":"Kent","year":"2010","journal-title":"Genes Dev"},{"key":"10.1016\/j.beem.2023.101741_bib126","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.beem.2023.101741_bib127","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fgene.2019.00478","article-title":"The potential for microRNA therapeutics and clinical research","volume":"10","author":"Hanna","year":"2019","journal-title":"Front Genet"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23000106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23000106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:03:50Z","timestamp":1778616230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X23000106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":127,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1521690X23000106"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2023.101741","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs in autoimmune thyroid diseases and their role as biomarkers","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2023.101741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101741"}}